✦ LIBER ✦

Fabrazyme® therapy in pediatric patients with Fabry disease: Improvements in quality-of-life measures

✍ Scribed by A. Tylki-Szymanska; D.P. Germain; J.E. Wraith; N. Guffon; Y.H. Lien; M. Tsimaratos; A. Vellodi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

64 Quality of life for pediatric patient

✍ Robert Hopkin; Heather M. Taylor; Laurie A. Bailey; Michael S. Yi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Long-term agalsidase beta therapy is ass

✍ N. Guffon; D.P. Germain; S. Waldek; M. Banikazemi; D.A. Bushinsky; J. Charrow; P 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Long-term improvements in quality-of-lif

✍ Emily F. Rudnick; Ron B. Mitchell 📂 Article 📅 2007 🏛 SAGE Publications 🌐 English ⚖ 149 KB

P20—Agalsidase Beta Treatment is Associa

✍ U. Feldt-Rasmussen; T. Watt; A.P. Burlina; C. Cazzorla; D. Schönfeld; M. Banikaz 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Measurement of quality of life in patien

✍ K Kawamoto; T Kamo; F Furukawa; N Horikawa; Y Higaki; M Kawashima; MM Chren 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Once-daily ciclesonide improves quality

✍ Miller, D.; Ratner, P.; Condemi, J.; Lawrence, M.; Crivera, C.; Lloyd, M.; Willi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 35 KB